RIM
CLB icon

RS Investment Management’s Core Laboratories CLB Stock Holding History

RS Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-34,955
Closed -$6.94M – 377
2014
Q1 		$6.94M Buy
34,955
+10,810
+45% +$2.04M 0.04% 251
2013
Q4 		$4.61M Sell
24,145
-1,565
-6% -$291K 0.03% 271
2013
Q3 		$4.35M Buy
25,710
+5,810
+29% +$902K 0.03% 252
2013
Q2 		$3.02M Buy
+19,900
New +$2.82M 0.02% 264

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

RS Investment Management's CLB Position: Q2 2014 in Review

RS Investment Management sold out of Core Laboratories (CLB) in Q2 2014, closing a stake of 34,955 shares — an estimated $6.94M sold.

RS Investment Management first reported a position in CLB in Q2 2013 and held it in 4 quarters. The position peaked at $6.94M in Q1 2014. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

  • RS Investment Management reported no remaining Core Laboratories position as of Q2 2014 after selling out during the quarter.
  • RS Investment Management sold 34,955 Core Laboratories shares in Q2 2014, an estimated $6.94M.
  • RS Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 4 quarters.
  • RS Investment Management's Core Laboratories position peaked at $6.94M in Q1 2014.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on RS Investment Management's 13F filing for Q2 2014, filed 15 Aug 2014.